News Releases
| 2012 | |||
| 03/02/2012 | MERCK SERONO AND THRESHOLD ANNOUNCE GLOBAL AGREEMENT TO CO-DEVELOP AND COMMERCIALIZE PHASE III HYPOXIA-TARGETED DRUG TH-302
Geneva, Switzerland | English | |
| 30/01/2012 | MERCK SERONO TO RAISE DONATION TENFOLD TO ELIMINATE WORM DISEASE
Geneva, Switzerland | English French German | |
| 25/01/2012 | MERCK SERONO RECEIVES EUROPEAN APPROVAL TO EXPAND USE OF REBIF® IN PATIENTS WITH EARLY MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 10/01/2012 | MERCK SERONO INITIATES VALIDATION STUDY OF THE FIRST QUALITY-OF-LIFE QUESTIONNAIRE SPECIFIC TO PHENYLKETONURIA
Geneva, Switzerland | English French German |
| 2011 | |||
| 13/12/2011 | MERCK SERONO HELPS ELIMINATE SCHISTOSOMIASIS IN AFRICA
Geneva, Switzerland | English French German | |
| 30/11/2011 | MERCK SERONO ANNOUNCES WINNER OF GLOBAL DESIGN COMPETITION FOR MULTIPLE SCLEROSIS COMMUNITY
Geneva, Switzerland | English French German | |
| 25/11/2011 | MERCK SERONO SUPPORTS THE CHIMISCOPE: AN EDUCATIONAL LABORATORY TO STIMULATE INTEREST IN CHEMISTRY
Geneva, Switzerland | English French German | |
| 18/11/2011 | MERCK SERONO: CHMP GIVES POSITIVE OPINION FOR EXTENDED INDICATION FOR REBIF® TO TREAT PATIENTS WITH EARLY SIGNS OF MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 14/11/2011 | MERCK SERONO TO MARK WORLD DIABETES DAY
FOR HIGH RESOLUTION PICTURES OF THE MERCK SERONO HEADQUARTERS LIT IN BLUE, CLICK HERE Geneva, Switzerland | English French German | |
| 09/11/2011 | MERCK SERONO AND ABLYNX EXPAND THEIR PARTNERSHIP INTO OSTEOARTHRITIS
Geneva, Switzerland | English French German | |
| 24/10/2011 | MERCK SERONO LAUNCHES EASYPOD™ CONNECT IN EUROPE
Geneva, Switzerland | English French German | |
| 21/10/2011 | FOUR FINALISTS OF GLOBAL DESIGN COMPETITION HIGHLIGHT NEED FOR INNOVATIVE SOLUTIONS FOR LIVING BETTER WITH MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 21/10/2011 | MERCK SERONO RETURNS RIGHTS FOR SAFINAMIDE TO NEWRON
Geneva, Switzerland | English French German | |
| 04/10/2011 | MERCK SERONO AND ONO PHARMACEUTICAL FORM COLLABORATIONS TO DEVELOP ORAL MULTIPLE SCLEROSIS DRUG AND CANCER IMMUNOTHERAPY
Geneva, Switzerland | English French German | |
| 28/09/2011 | MERCK SERONO ANNOUNCES ABOUT 30,000 PATIENTS TREATED WITH EASYPOD™, FIRST ELECTRONIC GROWTH HORMONE INJECTION DEVICE
Geneva, Switzerland | English French German | |
| 20/09/2011 | MERCK SERONO SUPPORTS CANCER PATIENTS IN THE LAKE GENEVA AREA
Geneva, Switzerland | English French German | |
| 19/09/2011 | MERCK SERONO ACQUIRES RIGHTS TO PI-2301 PROGRAM FOR MULTIPLE SCLEROSIS Geneva, Switzerland | English French German | |
| 12/09/2011 | MERCKSERONO JOINS THE FONDATION POUR GENEVE IN HONOURING THE RESEARCH ACHIEVED BY PROFESSOR DENIS DUBOULE
Geneva, Switzerland | English French German | |
| 07/09/2011 | MERCK SERONO AND F-STAR TO COLLABORATE IN THE DISCOVERY AND DEVELOPMENT OF NOVEL TARGETED BIOLOGICS
Geneva, Switzerland | English French German | |
| 07/09/2011 | MERCK SERONO ANNOUNCES CREATION OF ONCOLOGY CHAIR IN PARTNERSHIP WITH EPFL
Geneva, Switzerland | English French German | |
| 12/08/2011 | MERCK SERONO: FIRST INNOVATION CUP PROGRAM ENDED SUCCESSFULLY
Geneva, Switzerland | English French German | |
| 29/07/2011 | MERCK SERONO COMPLETES PATIENT ENROLLMENT IN SETTLE, A PHASE III PIVOTAL CLINICAL TRIAL OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE
Geneva, Switzerland | English French German | |
| 11/07/2011 | MERCK SERONO JOINED THE BIKE TO WORK CAMPAIGN: "DO SOME GOOD BOTH TO YOUR HEALTH AND TO THE ENVIRONMENT!"
Geneva, Switzerland | English French German Italian | |
| 07/07/2011 | MERCK SERONO STRENGTHENS EXECUTIVE MANAGEMENT TEAM WITH TWO APPOINTMENTS
For high resolution picture download click here Geneva, Switzerland | English French German | |
| 05/07/2011 | MERCK SERONO AWARDS GRANT TO INNOVATIVE RESEARCH PROJECTS IN FERTILITY
Geneva, Switzerland | English French German | |
| 04/07/2011 | MERCK SERONO RECEIVED EUROPEAN APPROVAL FOR THREE PRE-FILLED, READY-TO-USE PEN INJECTORS FOR FERTILITY TREATMENT
Geneva, Switzerland | English French German | |
| 30/06/2011 | MERCK SERONO AND FAST FORWARD ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH
Geneva, Switzerland | English French German | |
| 30/06/2011 | MERCK SERONO INITIATES PHASE IIIB EUROPEAN STUDY SPARK IN CHILDREN YOUNGER THAN FOUR YEARS, SUFFERING FROM PHENYLKETONURIA
Geneva, Switzerland | English French German | |
| 29/06/2011 | MERCK SERONO COMPLETES PATIENT ENROLLMENT IN MOTION, A PHASE III PIVOTAL CLINICAL TRIAL OF SAFINAMIDE IN EARLY PARKINSON’S DISEASE
Geneva, Switzerland | English French German | |
| 29/06/2011 | MERCK SERONO SUBMITS APPLICATION FOR EXTENSION OF INDICATION FOR REBIF® IN EUROPE
Geneva, Switzerland | English French German | |
| 22/06/2011 | MERCK SERONO: REGULATORY UPDATE ON CLADRIBINE TABLETS
Geneva, Switzerland | English French German | |
| 09/06/2011 | MERCK SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE’S PIVOTAL PHASE III TRIAL CENTRIC
Geneva, Switzerland | English | |
| 08/06/2011 | MERCK SERONO AND AFFECTIS PHARMACEUTICALS ANNOUNCE AN AGREEMENT TO DEVELOP ORAL DRUGS FOR NEURODEGENERATIVE DISEASES
Geneva, Switzerland | English French German | |
| 04/06/2011 | ASCO 2011: ERBITUX INCREASED OVERALL SURVIVAL BY 5.1 MONTHS IN PATIENTS WITH MCRC THAT HAS SPREAD BEYOND THE LIVER
Geneva, Switzerland | English | |
| 25/05/2011 | MERCK SERONO COMMITS TO SUPPORT PEOPLE LIVING WITH MULTIPLE SCLEROSIS AT WORK
Geneva, Switzerland | English French German | |
| 23/05/2011 | MERCK SERONO SUPPORTS FOR THE THIRD YEAR THE INTERNATIONAL THYROID AWARENESS WEEK
Geneva, Switzerland | English French German | |
| 04/05/2011 | MERCK SERONO MET A DISPOSITION LA RESERVE NATURELLE "EN PRAZ-LIBON" A PRO NATURA POUR LA PRESERVATION D’UNE ESPECE MENACEE DE CRAPAUDS
Geneva, Switzerland | French German | |
| 29/04/2011 | MERCK SERONO: NEW PRESENTATION OF CYANOKIT® APPROVED BY U.S. FDA
Geneva, Switzerland | English French German | |
| 28/04/2011 | MERCK SERONO PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL HOSPITAL
Geneva, Switzerland | English French German | |
| 19/04/2011 | PUBLICATION OF SURVIVAL BENEFIT IN LEADING JOURNAL EMPHASIZES IMPORTANCE OF ERBITUX IN 1ST LINE MCRC
Geneva, Switzerland | English | |
| 13/04/2011 | MERCK SERONO: DATA ON PARKINSON’S DISEASE INVESTIGATIONAL DRUG SAFINAMIDE TO BE PRESENTED AT AAN 2011 ANNUAL MEETING Geneva, Switzerland | English French German | |
| 08/04/2011 | MERCK SERONO’S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING
Geneva, Switzerland | English
French German | |
| 31/03/2011 | MERCK SERONO AND NEWRON TO BROADEN COLLABORATION ON NEW THERAPIES FOR CENTRAL NERVOUS SYSTEM DISEASES
Geneva, Switzerland | English
French German | |
| 30/03/2011 | MERCK SERONO INITIATES STRATEGIC ISRAEL BIOINCUBATOR FUND
Geneva, Switzerland | English
French German Hebrew | |
| 30/03/2011 | ERBITUX INDICATION EXTENSION SUBMITTED FOR FIRST-LINE ADVANCED OR METASTATIC NSCLC IN THE EU
Geneva, Switzerland | English | |
| 15/03/2011 | GLOBAL COMPETITION CELEBRATES INNOVATION AND INSPIRATION OF MULTIPLE SCLEROSIS COMMUNITY
Geneva, Switzerland | ||
| 14/03/2011 | MERCK SERONO OPENS DOORS TO BUDDING SCIENTISTS
Geneva, Switzerland | ||
| 02/03/2011 | MERCK SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Geneva, Switzerland | English French German | |
| 15/02/2011 | MERCK SERONO LAUNCHES INNOVATION CUP 2011
Geneva, Switzerland | English French German | |
| 14/02/2011 | MERCK SERONO INITIATES THE FIRST OBSERVATIONAL STUDY TO EVALUATE ADHERENCE AND CLINICAL OUTCOMES OF GROWTH HORMONE SAIZEN® IN PATIENTS USING EASYPOD™ Geneva, Switzerland | English French German | |
| 10/02/2011 | MERCK SERONO LAUNCHES UNITEMS.NET – A PIONEERING SOCIAL NETWORK AND ONLINE RESOURCE FOR THE MULTIPLE SCLEROSIS COMMUNITY
Geneva, Switzerland | English French German | |
| 04/02/2011 | MERCK SERONO LAUNCH LATEST IN SERIES OF ONGOING DISEASE AWARENESS INITIATIVES
Geneva, Switzerland | English | |
| 21/01/2011 | MERCK SERONO ANNOUNCES OUTCOME OF ITS REQUEST FOR REEXAMINATION OF CHMP OPINION FOR CLADRIBINE TABLETS IN MS
Geneva, Switzerland | English French German | |
| 17/01/2011 | MERCK SERONO AND DOMAIN THERAPEUTICS ANNOUNCE AN AGREEMENT TO DEVELOP DRUGS FOR PARKINSON’S DISEASE
Geneva, Switzerland | English French German | |
| 12/01/2011 | BRIGHTER FUTURES IN MS - INSPIRING SHORT FILM PREMIERES IN BRUSSELS
Geneva, Switzerland | ||
| 05/01/2011 | EXPAND STUDY INVESTIGATING ERBITUX AS 1ST LINE TREATMENT IN ADVANCED GASTRIC CANCER COMPLETES RECRUITMENT
Geneva, Switzerland | English |
| 2010 | |||
| 21/12/2010 | MERCK SERONO AND PHILOCHEM ENTER INTO RESEARCH AGREEMENT IN FERTILITY
Geneva, Switzerland | English French German | |
| 17/12/2010 | MERCK SERONO AND SANOFI-AVENTIS ANNOUNCE AGREEMENT TO JOINTLY INVESTIGATE NOVEL COMBINATIONS AGAINST CANCER
Geneva, Switzerland | English | |
| 13/12/2010 | MERCK SERONO AND SAN RAFFAELE SCIENTIFIC INSTITUTE TO COLLABORATE ON RESEARCH IN NEURODEGENERATIVE DISEASES
Geneva, Switzerland | English French German | |
| 26/11/2010 | MERCK SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 17/11/2010 | MERCK SERONO: ENROLLMENT COMPLETED FOR ORACLE MS STUDY OF CLADRIBINE TABLETS IN PATIENTS AT RISK OF DEVELOPING MS
Geneva, Switzerland | English French German | |
| 15/11/2010 | MERCK SERONO: READY-TO-USE FORMULATION OF RECOMBINANT GROWTH HORMONE SAIZEN RECOMMENDED FOR APPROVAL IN EUROPE
Geneva, Switzerland | English French German | |
| 11/11/2010 | FDA APPROVES EGRIFTA™ (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Geneva, Switzerland | English French German | |
| 04/11/2010 | MERCK SERONO ANNOUNCES TOP-LINE RESULTS OF LONG-TERM STUDY OF SAFINAMIDE AS ADD-ON TREATMENT TO LEVODOPA IN ADVANCED PARKINSON’S DISEASE
Geneva, Switzerland | English French German | |
| 28/10/2010 | MERCK SERONO SELLS THÉRAMEX TO TEVA FOR EUR 265 MILLION
Geneva, Switzerland | English French German | |
| 25/10/2010 | MERCK SERONO: REFLEX STUDY RESULTS SHOW TREATMENT WITH REBIF® DELAYS CONVERSION TO MS IN PATIENTS WITH FIRST CLINICAL SIGNS OF THE DISEASE
Geneva, Switzerland | English French German | |
| 15/10/2010 | MERCK SERONO TO INTRODUCE REBIDOSE™, THE REBIF® SINGLE USE PRE-FILLED PEN FOR TREATMENT OF MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 13/10/2010 | MERCK SERONO: NEW PRESENTATION OF CYANOKIT® APPROVED IN EUROPE
Geneva, Switzerland | English French German | |
| 11/10/2010 | RESULTS OF A RANDOMIZED PHASE II STUDY WITH ERBITUX IN BREAST CANCER HIGHLIGHTED IN ESMO 2010 PRESIDENTIAL SYMPOSIUM
Geneva, Switzerland | English | |
| 11/10/2010 | SURVEYS HIGHLIGHT ADVANCING CONFIDENCE IN ERBITUX AS ONLY TARGETED TREATMENT TO INCREASE SURVIVAL AND POTENTIAL FOR CURE IN HEAD AND NECK CANCER
Geneva, Switzerland | English | |
| 11/10/2010 | MERCK SERONO NOTIFIED EMA OF ITS INTENTION TO APPEAL CHMP OPINION ON CLADRIBINE TABLETS IN MS
Geneva, Switzerland | English French German | |
| 11/10/2010 | ABLYNX AND MERCK SERONO ENTER INTO SECOND AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES®
Geneva, Switzerland | English French German | |
| 10/10/2010 | EARLY TUMOR SHRINKAGE WITH FIRST-LINE ERBITUX THERAPY LEADS TO LONGEST-EVER MEDIAN SURVIVAL IN KRAS WILD-TYPE MCRC
Geneva, Switzerland | English | |
| 08/10/2010 | MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Geneva, Switzerland | English French German | |
| 04/10/2010 | NEW DATA FOR ERBITUX IN PREVALENT CANCERS TO BE REVEALED AT ESMO
Geneva, Switzerland | English | |
| 04/10/2010 | MERCK SERONO ANNOUNCES WINNER OF THE REAL MS: YOUR STORY COMPETITION – SCRIPT TO BE MADE INTO AN INTERNATIONAL SHORT FILM ON MULTIPLE SCLEROSIS DIRECTED BY ROBIN SHEPPARD
Geneva, Switzerland | English French German | |
| 24/09/2010 | MERCK SERONO ANNOUNCES CHMP OPINION FOR CLADRIBINE TABLETS IN MS
Geneva, Switzerland | English French German | |
| 03/09/2010 | MERCK SERONO’S CLADRIBINE TABLETS FOR MS APPROVED IN AUSTRALIA
Geneva, Switzerland | English French German | |
| 01/09/2010 | US EDUCATIONAL SUPPORT SERVICE FOR MS COMMUNITY, MS LIFELINES®, REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS
Geneva, Switzerland | English French German | |
| 28/07/2010 | MERCK SERONO: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS
Geneva, Switzerland | English French German | |
| 12/07/2010 | MERCK SERONO’S CLADRIBINE TABLETS FOR MS APPROVED IN RUSSIA
Geneva, Switzerland | English French German | |
| 29/06/2010 | MERCK SERONO TO AWARD GRANT TO INNOVATIVE RESEARCH PROJECTS IN FERTILITY
Geneva, Switzerland | English French German | |
| 28/06/2010 | FINDINGS FROM GLOBAL SURVEY HELP UNDERSTAND FERTILITY TRENDS AND BARRIERS TO SEEKING MEDICAL HELP AGAINST INFERTILITY
Geneva, Switzerland | English French German | |
| 25/06/2010 | MERCK SERONO CALLS FOR ENTRIES TO REAL MS - YOUR STORY, A GLOBAL COMPETITION TO RAISE AWARENESS OF MULTIPLE SCLEROSIS Geneva, Switzerland | English French German | |
| 17/06/2010 | Data to Be Presented at ENS 2010 Meeting Underscore Merck Serono’s Commitment to Advance Multiple Sclerosis Care and Research Geneva, Switzerland | English French German | |
| 17/06/2010 | Merck Serono Resumes Stimuvax Clinical Program in Lung Cancer Geneva, Switzerland | English | |
| 10/06/2010 | MERCK SERONO: DATA ON SAFINAMIDE TO BE PRESENTED AT THE 14TH MDS MEETING
Geneva, Switzerland | English French German | |
| 08/06/2010 | MERCK SERONO RESUBMITS U.S. APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL MS THERAPY
Geneva, Switzerland | ||
| 05/06/2010 | Cilengitide Study Provides Long-Term Follow-up Data in Glioblastoma Patients Receiving Investigational Drug for More Than 4 Years
Geneva, Switzerland | English | |
| 01/06/2010 | GLOBAL SURVEY REVEALS ERBITUX IS NOW A STANDARD OF CARE FOR CONFIRMED KRAS WILD-TYPE METASTATIC COLORECTAL CANCER
Geneva, Switzerland | English | |
| 26/05/2010 | YOUR STORY, YOUR VOICE, YOUR ACHIEVEMENTS, YOUR IDEAS… THIS IS ABOUT LIFE, REAL LIFE, REAL MS
Geneva, Switzerland | English French | |
| 25/05/2010 | INTERNATIONAL THYROID AWARENESS WEEK 2010 TO FOCUS ON THYROID DISORDERS AND PREGNANCY
Geneva, Switzerland | ||
| 21/05/2010 | MERCK SERONO PRESENTS FURTHER EVIDENCE OF SUSTAINED INNOVATION IN ONCOLOGY AT ASCO 2010
Geneva, Switzerland | English | |
| 05/05/2010 | MERCK SERONO AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS Geneva, Switzerland | ||
| 03/05/2010 | MERCK SERONO NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE Geneva, Switzerland | ||
| 22/04/2010 | MERCK SERONO CORPORATE HEADQUARTERS RECEIVES ISO 14001 CERTIFICATION Geneva, Switzerland | ||
| 16/04/2010 | New Data Supporting Cladribine Tablets as a Potential New Therapeutic Option Presented at the62nd AAN Annual Meeting Toronto, Canada / Geneva, Switzerland | English French German | |
| 31/03/2010 | Data from Merck Serono’s Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of Neurology Geneva, Switzerland | English French German | |
| 29/03/2010 | MERCK SERONO: Erbitux Granted extended Use in Japan for First-Line-Treatment for mCRC-Patients with KRAS wild-type Tumors
Geneva, Switzerland | English | |
| 23/03/2010 | MERCK SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED
Geneva, Switzerland | English | |
| 04/03/2010 | CARDIFF UNIVERSITY AND MERCK SERONO LAUNCH INTERNATIONAL SURVEY FOR COUPLES TRYING TO CONCEIVE
| English French German | |
| 24/01/2010 | ASCO-GI: OVERALL SURVIVAL WITH ERBITUX IS SIGNIFICANTLY IMPROVED IN PATIENTS WITH KRAS WILD-TYPE TUMORS IN CRYSTAL
Geneva, Switzerland | English | |
| 21/01/2010 | TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE
Geneva, Switzerland | ||
| 18/01/2010 | LE MAGAZINE BILAN PLACE MERCK SERONO EN TETE DE SON PALMARES 2010 DES MEILLEURS EMPLOYEURS DE SUISSE ROMANDE
Geneva, Switzerland | French |
| 2009 | |||
| 16/12/2009 | MERCK SERONO ANNOUNCES COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS
Geneva, Switzerland | English French German | |
| 10/12/2009 | MERCK SERONO STARTS STIMUVAX PHASE III STUDY INSPIRE IN ASIAN PATIENTS WITH ADVANCED NSCLC
| English | |
| 10/12/2009 | MERCK Serono Initiates KAMPER, The First Pan-European Registry for Patients Under Kuvan® therapy
Geneva, Switzerland | English French German | |
| 30/11/2009 | MERCK SERONO RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Geneva, Switzerland | English French German | |
| 25/11/2009 | MERCK SERONO LAUNCHES NEW WEBSITE ON PHENYLKETONURIA
Geneva, Switzerland | English French German | |
| 19/11/2009 | MERCK SERONO TO EXPAND RESEARCH AND DEVELOPMENT PRESENCE IN CHINA
Geneva, Switzerland | English French German | |
| 19/11/2009 | MERCK SERONO: CHMP OPINION FOR ERBITUX IN ADVANCED NON-SMALL CELL LUNG CANCER
Geneva, Switzerland | English | |
| 16/11/2009 | ERBITUX RECOGNIZED BY ASCO AS A 2009 MAJOR CANCER ADVANCE AS FIRST SCCHN TREATMENT TO IMPROVE SURVIVAL IN 30 YEARS
| English | |
| 06/11/2009 | PETACC-8 STUDY INVESTIGATING ERBITUX AS ADJUVANT TREATMENT IN COLON CANCER COMPLETES RECRUITMENT
Geneva, Switzerland | English | |
| 15/10/2009 | MERCK SERONO REÇOIT LE PRIX DE L’INDUSTRIE DE GENEVE
Geneva, Switzerland | French | |
| 05/10/2009 | MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Geneva, Switzerland | English French German | |
| 30/09/2009 | MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES
Geneva, Switzerland | English French German | |
| 23/09/2009 | INITIAL COIN STUDY RESULTS PRESENTED AT EUROPEAN ONCOLOGY CONGRESS
Geneva, Switzerland | English | |
| 16/09/2009 | MERCK SERONO GROWTH HORMONE INJECTION DEVICE EASYPOD® APPROVED IN JAPAN
Geneva, Switzerland | English French German | |
| 14/09/2009 | RESULTS OF REBISMART™ USER TRIAL PRESENTED AT 25TH ECTRIMS CONGRESS SHOW BROAD PATIENT ACCEPTANCE OF THE NEW ELECTRONIC DELIVERY DEVICE FOR RELAPSING MULTIPLE SCLEROSIS TREATMENT REBIF® Geneva, Switzerland | English French German | |
| 11/09/2009 | Results from IMPROVE Study Show MRI Benefits of Rebif® Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and Sustained Over Time Geneva, Switzerland | English French German | |
| 11/09/2009 | NEW DATA FROM CLARITY STUDY ON DISEASE ACTIVITY IN MS PATIENTS WHO RECEIVED CLADRIBINE TABLETS PRESENTED AT 25TH ECTRIMS CONGRESS
Düsseldorf, Germany, and Geneva, Switzerland | English French German | |
| 10/08/2009 | EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH AND CLINICAL TRIALS
Darmstadt, Germany | English | |
| 04/08/2009 | DATA PRESENTED ON MERCK SERONO’S CILENGITIDE SUPPORT ONGOING CLINICAL EVALUATION IN NSCLC
San Francisco, CA, USA/Darmstadt Germany | English | |
| 02/08/2009 | Merck Serono Presented New Data On the Combination of Erbitux with Standard First-Line Therapy in Patients with NSCLC
San Francisco, CA, USA / Geneva, Switzerland | English | |
| 31/07/2009 | MERCK SERONO Has Requested Re-examination of the CHMP Opinion for Erbitux in Non-Small Cell Lung Cancer
Geneva, Switzerland | English | |
| 24/07/2009 | MERCK SERONO CONSIDERS APPEALING CHMP OPINION ON ERBITUX TREATMENT FOR NON-SMALL CELL LUNG CANCER
Geneva, Switzerland | English | |
| 23/07/2009 | MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS
AS MULTIPLE SCLEROSIS THERAPY IN EUROPE Geneva, Switzerland | English French German | |
| 16/07/2009 | GONAL-F APPROVED IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN
Geneva, Switzerland | English French German | |
| 15/07/2009 | MERCK SERONO ANNOUNCES LICENSE AGREEMENT WITH BIOWA FOR POTELLIGENT® TECHNOLOGY
Darmstadt, Germany | English | |
| 01/07/2009 | MERCK SERONO LAUNCHES “GLOBAL FERTILITY ACADEMY” TO PROVIDE EDUCATION AND TRAINING FOR THE TREATMENT OF INFERTILITY
Geneva, Switzerland | English French German | |
| 24/06/2009 | MERCK SERONO: LATEST ERBITUX DATA ON METASTATIC COLORECTAL CANCER PRESENTED AT WCGIC UNDERLINE BENEFITS IN PATIENTS WITH KRAS WILD-TYPE TUMORS
Barcelona, Spain/Darmstadt, Germany | English | |
| 24/06/2009 | MERCK SERONO LAUNCHES REBISMART™, FIRST ELECTRONIC INJECTION DEVICE FOR DELIVERY OF MULTIPLE SCLEROSIS TREATMENT REBIF®
Geneva, Switzerland | English French German Italian | |
| 22/06/2009 | NEW DATA FROM CLARITY STUDY PRESENTED AT 19TH ENS MEETING SHOW RAPID AND SUSTAINED MS RELAPSE REDUCTION FOR CLADRIBINE TABLETS
Geneva, Switzerland | English French German Italian | |
| 22/06/2009 | MERCK SERONO INITIATES PHASE III STUDY OF STIMUVAX IN BREAST CANCER Geneva, Switzerland | English | |
| 03/06/2009 | FIRST PHASE III CLINICAL TRIAL RESULTS OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE TO BE PRESENTED AT THE MOVEMENT DISORDER SOCIETY 13TH INTERNATIONAL CONGRESS
| English French German | |
| 01/06/2009 | UK’S NICE RECOMMENDS USE OF ERBITUX FOR METASTATIC COLORECTAL CANCER PATIENTS
Geneva, Switzerland | English | |
| 31/05/2009 | MERCK SERONO AT FOREFRONT OF EXPLORING MARKERS OF RESPONSE IN CONTINUED EFFORT TO PERSONALIZE CANCER CARE
Orlando, FL, USA / Geneva, Switzerland | English | |
| 31/05/2009 | STUDY SHOWS CILENGITIDE INCREASED OVERALL SURVIVAL IN PATIENTS WITH GLIOBLASTOMA
Orlando, FL, USA / Geneva, Switzerland | English | |
| 30/05/2009 | FOLLOW-UP FROM STIMUVAX STUDY PROVIDES LONG-TERM SAFETY DATA IN ADVANCED LUNG CANCER PATIENTS RECEIVING TREATMENT FOR UP TO 8.2 YEARS
Orlando, FL, USA / Geneva, Switzerland | English | |
| 25/05/2009 | MERCK SERONO To Support First International Thyroid Awareness Week
Geneva, Switzerland | English French German | |
| 18/05/2009 | MERCK SERONO COMMITTED TO INVESTING IN INNOVATION IN THE FERTILITY AREA
Geneva, Switzerland | English French German | |
| 14/05/2009 | MERCK SERONO CHAMPIONS PERSONALIZED CANCER CARE WITH TARGETED THERAPIES
Darmstadt, Germany | English | |
| 07/05/2009 | RESULTS AT ASCO CONGRESS 2009 HIGHLIGHT MERCK SERONO'S LEADERSHIP IN PERSONALIZING CANCER CARE
Geneva, Switzerland | English | |
| 07/05/2009 | MERCK SERONO INITIATES SETTLE, THE SECOND PHASE III CLINICAL TRIAL OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE
Geneva, Switzerland | English French German | |
| 05/05/2009 | Merck Serono Launches Glucophage Powder in First European Countries
Geneva, Switzerland | English French German | |
| 01/05/2009 | STUDY PUBLISHED IN THE LANCET SHOWS ERBITUX SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN 1ST-LINE NSCLC
Darmstadt, Germany | English | |
| 30/04/2009 | Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with Multiple Sclerosis | ||
| 21/04/2009 | MERCK SERONO LAUNCHES Kuvan ® in europe
Geneva, Switzerland | English German French | |
| 02/04/2009 | MERCK SERONO: PHASE III ERBITUX DATA PUBLISHED IN NEJM CONFIRMENHANCED EFFICACY IN MCRC PATIENTS IN THE 1ST-LINE SETTING
Darmstadt, Germany | English | |
| 30/03/2009 | Merck Serono: New Phase III Data for Cladribine Tablets
| English German French | |
| 23/03/2009 | MERCK SERONO LAUNCHES STRATEGIC VENTURE CAPITAL FUND Geneva, Switzerland | English German French | |
| 18/03/2009 | Merck Serono and Fast Forward, LLCAnnounce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis | English German French | |
| 24/02/2009 | MERCK SERONO AND AMBRX EXPAND COLLABORATION THROUGH ARX424 MULTIPLE SCLEROSIS DRUG DEVELOPMENT ALLIANCE
Geneva, Switzerland | English German French | |
| 19/02/2009 | EUROPEAN MEDICINES AGENCY RECOMMENDS SUSPENSION OF MARKETING AUTHORIZATION FOR RAPTIVA®
| English German French | |
| 16/03/2009 | MERCK SERONO EXPANDS CILENGITIDE DEVELOPMENT PROGRAM
| English | |
| 03/02/2009 | Merck Serono’s Safinamide Significantly Improved Motor Function in Patients with Advanced Parkinson’s Disease in a Phase III Pivotal Trial
| English German French | |
| 23/01/2009 | MERCK SERONO LAUNCHES ERBITUX IN 1ST-LINE TREATMENT OF HEAD AND NECK CANCER IN EUROPE
Antwerp, Belgium | English | |
| 23/01/2009 | MERCK SERONO´S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL Geneva, Switzerland | English German French | |
| 13/01/2009
| MERCK SERONO AND APITOPE ANNOUNCE LICENSING AGREEMENT ON NOVEL PEPTIDE THERAPEUTICS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Geneva, Switzerland | English German French |
| 2008 | |||
| 19/12/2008 | MERCK SERONO AQUIRES MANUFACTURING RIGHTS AND FACILITY FOR STIMUVAX FROM ONCOTHYREON Geneva, Switzerland | English | |
| 09/12/2008
| MERCK SERONO’S KUVAN® RECEIVES MARKETING AUTHORIZATION IN EUROPE | English German French | |
| 01/12/2008 | MERCK SERONO: EUROPEAN COMMISSION APPROVES ERBITUX FOR FIRST-LINE USE IN HEAD AND NECK CANCER
Geneva, Switzerland | English | |
| 13/11/2008 | MERCK SERONO: OVERALL SURVIVAL IN FIRST-LINE NSCLC REACHES 15 MONTHS WITH ERBITUX Geneva, Switzerland | English | |
| 12/11/2008 | MERCK SERONO LAUNCHES EXPANSION OF FLAGSHIP BIOTECH CENTER TO MEET GROWING PATIENT NEEDS Geneva, Switzerland | ||
| 29/10/2008 | MERCK SERONO’S US AFFILIATE EMD SERONO, INC. AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES | English German | |
| 29/10/2008 | MERCK SERONO AND LPATH FORM ALLIANCE FOR ASONEP Gerneva, Switzerland | English | |
| 24/10/2008 | MERCK SERONO SUBMITS APPLICATION FOR GONAL-F® IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN Gerneva, Switzerland | English German French | |
| 24/10/2008 | MERCK SERONO: ERBITUX RECEIVES CHMP POSITIVE OPINION FOR FIRST-LINE USE IN HEAD AND NECK CANCER Geneva, Switzerland | English | |
| 14/10/2008 | MICHAEL J. FOX FOUNDATION AWARDS $2 MILLION GRANT FROM MERCK SERONO TO RESEARCH PROJECTS ON COGNITIVE DEFICITS IN PARKINSON´S DISEASE Geneva, Switzerland | English German French | |
| 10/10/2008 | MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Geneva, Switzerland | English German French | |
| 03/10/2008 | SEVERE ADVERSE EVENT REPORTED IN RAPTIVA® PATIENT Geneva, Switzerland | English German French | |
| 01/10/2008 | MERCK SERONO AMONG THE WINNERS IN THE GERMAN BIOPHARMA STRATEGY COMPETITION Geneva, Switzerland | English German | |
| 29/09/2008 | MERCK SERONO RECOGNIZED FOR STRATEGIC LEADERSHIP IN HUMAN RESOURCES Geneva, Switzerland | English German French | |
| 26/09/2008 | MERCK SERONO´S KUVAN® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland | English German French | |
| 23/09/2008 | MERCK SERONO ANNOUNCES ONE-MONTH RESULTS OF PHARMACOGENOMICS STUDY PREDICT AT 47TH ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY Geneva, Switzerland | English German French | |
| 22/09/2008 | RESULTS FROM IMPROVE STUDY SHOW THERAPEUTIC EFFECT OF NEW FORMULATION OF REBIF® AT 16 WEEK IN PATIENTS WITH MULTIPLE SCLEROSIS
Geneva, Switzerland | ||
| 18/09/2008 | MERCK SERONO ANNOUNCES INITIATION OF THE ORACLE MS TRIAL TO EVALUATE CLADRIBINE TABLETSIN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 17/09/2008 | MERCK SERONO COMPLETES ENROLLMENT IN THE REFLEX TRIAL OF REBIF® IN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS | English German French | |
| 11/09/2008 | MERCK SERONO SUBMITS NEW LICENSE APPLICATION FOR ERBITUX IN FIRST-LINE NON-SMALL CELL LUNG CANCER IN EUROPE Geneva, Switzerland | English | |
| 10/09/2008 | GLUCOPHAGE® POWDER FOR ORAL SOLUTION IN SACHET RECEIVES POSITIVE OPINION FOR APPROVAL IN EUROPE | English German French | |
| 04/09/2008 | MERCK SERONO AND ABLYNX ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES® Geneva, Switzerland | English German French | |
| 03/09/2008 | MERCK SERONO AND ZYMOGENETICS RESTRUCTURE PARTNERSHIP Geneva, Switzerland | English German French | |
| 16/07/2008 | MERCK SERONO: ERBITUX APPROVED FOR USE IN METASTATIC COLORECTAL CANCER IN JAPAN Geneva, Switzerland | English | |
| 09/07/2008 | MERCK SERONO: ERBITUX® PHASE III CLINICAL STUDY IN GASTRIC CANCER STARTED Geneva, Switzerland | English | |
| 01/07/2008 | EMEA CONFIRMS POSITIVE BENEFIT-RISK BALANCE WITH RAPTIVA® FOR THE TREATMENT OF PSORIASIS
Geneva, Switzerland | English German French | |
| 19/06/2008 | MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX FOR FIRST-LINE HEAD AND NECK CANCER IN EUROPE
Geneva, Switzerland | English | |
| 18/06/2008 | MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT
Geneva, Switzerland | English German French | |
| 18/06/2008 | RENOUVELLEMENT DE LA CERTIFICATION ENVIRONNEMENTALE DU SITE DE PRODUCTION DE MERCK SERONO À CORSIER-SUR-VEVEY Genève, Suisse | German French | |
| 10/06/2008 | MERCK SERONO STRENGTHENS ITS PRESCRIPTION MEDICINES PORTFOLIO IN LATIN AMERICA Geneva, Switzerland | English German French | |
| 10/06/2008 | MERCK SERONO’S REBIF® CELEBRATES 10TH ANNIVERSARY Geneva, Swizterland | English German French | |
| 05/06/2008 | MERCK SERONO ANNOUNCES INITIATION OF SECOND PHASE II/III CLINICAL STUDY OF ATACICEPT IN LUPUS
Geneva, Switzerland | English German French | |
| 31/05/2008 | MERCK SERONO: ERBITUX SIGNIFICANTLY PROLONGS SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland | English | |
| 30/05/2008 | MERCK SERONO A DÉPOSÉ LA DERNIÈRE DEMANDE DE PERMIS DE CONSTRUIRE RELATIVE AU PROJET D’EXTENSION DE SON SITE DE PRODUCTION DE CORSIER-SUR-VEVEY Genève, Suisse | German French | |
| 15/05/2008 | PROJET D’EXTENSION DU SITE DE MERCK SERONO À CORSIER-SUR-VEVEY : CONCLUSIONS DE LA NOTICE D’IMPACT SUR L’ENVIRONNEMENT Genève, Suisse | German French | |
| 05/05/2008 | UNIQUE THREE-YEAR DATA DEMONSTRATING LONG-TERM EFFICACY AND SAFETY OF RAPTIVA® IN THE TREATMENT OF PSORIASIS PUBLISHED IN THE BRITISH JOURNAL OF DERMATOLOGY Geneva, Switzerland | English German French | |
| 30/04/2008 | MERCK SERONO ANNOUNCES INITIATION OF PHASE II CLINICAL TRIAL OF ATACICEPT IN RELAPSING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 16/04/2008 | MERCK ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN THE US Geneva, Switzerland | English German French |
| 2007 | |||
| 20/12/2007 | MERCK SERONO AND FLAMEL TO COLLABORATE ON AN EXTENDED RELEASE FORMULATION FOR THERAPEUTIC PROTEINS
Geneva, Switzerland | English German French | |
| 19/12/2007 | MERCK KGAA IDERA PHARMACEUTICALS TO COLLABORATE ON DEVELOPMENT OF TLR9 AGONISTS FOR TREATMENT OF CANCER
| English German | |
| 18/12/2007 | MERCK SERONO LAUNCHES NEW WEBSITE Geneva, Switzerland | English German French | |
| 13/12/2007 | MERCK SERONO ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH Geneva, Switzerland | English German French | |
| 13/12/2007 | MERCK SERONO ANNOUNCES INITIATION OF PHASE II/III CLINICAL TRIAL OF ATACICEPT IN LUPUS NEPHRITIS Geneva, Switzerland | English German French | |
| 29/11/2007 | NEW DATA HIGHLIGHT THAT TREATMENT WITH ERBITUX ALLOWS MORE RESECTIONS OF PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 29/11/2007 | MERCK SERONO’S CYANOKIT® APPROVED IN THE EUROPEAN UNION Geneva, Switzerland | English German French | |
| 28/11/2007 | MERCK SERONO INITIATES THE MOTION STUDY, A NEW PHASE III CLINICAL TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE
Geneva, Switzerland | English German French | |
| 14/11/2007 | STUDY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE SHOWS ERBITUX IMPROVES SURVIVAL IN METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 08/11/2007 | MERCK SERONO SUBMITS EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR SAPROPTERIN AS A TREATMENT FOR HYPERPHENYLALANINEMIA Geneva, Switzerland | English German French | |
| 08/11/2007 | FDA APPROVAL OF EASYPOD®: NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICE Geneva, Switzerland | English German French | |
| 31/10/2007 | MERCK SERONO AND EPFL ANNOUNCE RESEARCH PARTNERSHIP IN NEUROSCIENCE, ONCOLOGY AND DRUG DELIVERY Geneva, Switzerland | English German French | |
| 17/10/2007 | MERCK SERONO ANNOUNCES JOINT AGREEMENT WITH IMCLONE AND BRISTOL-MYERS SQUIBB FOR ERBITUX IN JAPAN Geneva, Switzerland | English | |
| 11/10/2007 | TWO-YEAR PHASE IIIB DATA SHOW THAT THE NEW FORMULATION OF REBIF® OFFERS A NEAR THREE-FOLD IMPROVEMENT IN INJECTION TOLERABILITY AND REDUCED IMMUNOGENICITY
Geneva, Switzerland | English German French | |
| 26/09/2007 | DATA REINFORCE THE VALUE OF UFT® AS AN IMPORTANT TREATMENT OPTION FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland | English | |
| 25/09/2007 | SAFETY AND EFFICACY OF ERBITUX® CONFIRMED FOR COMBINATION TRIALS Geneva, Switzerland | English | |
| 24/09/2007 | MERCK SERONO’S CYANOKIT® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland | English German | |
| 11/09/2007 | ERBITUX PHASE III STUDY – FLEX INCREASES OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland | English | |
| 05/09/2007 | STIMUVAX® THERAPEUTIC CANCER VACCINE – PHASE II DATA HIGHLIGHT THREE-YEAR SURVIVAL RESULTS FOR LUNG CANCER PATIENTS Geneva, Switzerland | English | |
| 03/09/2007 | MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX® FOR 1ST-LINE COLORECTAL CANCER
Geneva, Switzerland | English | |
| 30/08/2007 | NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® APPROVED IN EUROPEAN UNION Geneva, Switzerland | English German French | |
| 29/08/2007 | MERCK SERONO TO RECONSIDER DEVELOPMENT OF MATUZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS
Geneva, Switzerland | English | |
| 22/08/2007 | MERCK SERONO ANNOUNCES 18-MONTH SAFETY AND EFFICACY DATAOF PHASE III TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE Geneva, Switzerland | English | |
| 06/07/2007 | SQUEEZE OUT OF MERCK SERONO SHARES SUCCESSFULLY COMPLETED
Geneva, Switzerland | English German French | |
| 29/06/2007 | MERCK SERONO’S FERTILITY TREATMENT PERGOVERIS™ APPROVED IN EUROPEAN UNION Geneva, Switzerland | English German French | |
| 28/06/2007 | EUROPEAN UNION CHMP RECOMMENDS APPROVAL OF NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® (INTERFERON BETA-1A)
Geneva, Switzerland | English German French | |
| 19/06/2007 | MERCK SERONO AND AMBRX TO COLLABORATE ON DEVELOPMENT OF NEXT GENERATION GROWTH HORMONE PRODUCTS Geneva, Switzerland | English German French | |
| 18/06/2007 | EASYPOD™ PATIENT FRIENDLY INJECTION DEVICE RECOGNIZED BY TECHNOLOGY AWARD Geneva, Switzerland | English German French | |
| 15/06/2007 | INAUGURATION OF MERCK SERONO’S NEW GLOBAL HEAD OFFICE IN GENEVA
Geneva, Switzerland | English German French | |
| 08/06/2007 | PROMISING DATA ON COGNITIVE EFFECTS OF SAFINAMIDEIN EARLY PARKINSON’S DISEASE Geneva, Switzerland | English German French | |
| 04/06/2007 | MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT Geneva, Switzerland | English German French | |
| 04/06/2007 | CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007 Geneva, Switzerland | English French | |
| 16/05/2007 | INAUGURATION DE L’ESPACE DE VIE ENFANTINE CRESCENDO Genéve, Suisse | French | |
| 02/05/2007 | PHASE III DATA ON SAFINAMIDE IN PARKINSON'S DISEASE PRESENTED AT AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING
Geneva, Siwtzerland | English French | |
| 27/04/2007 | MERCK SERONO ANNOUNCES PRESENTATION OF PHASE III CLINICAL DATA ON SAFINAMIDE IN PARKINSON’S DISEASE AT THE AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING Geneva, Switzerland | German French | |
| 05/04/2007 | MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS) Geneva, Switerland | English German French | |
| 21/03/2007 | MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES
Geneva, Switzerland | English German French | |
| 21/03/2007 | MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A.
Geneva, Switzerland | English German French | |
| 01/03/2007 | MERCK KGAA ANNOUNCES SERONO PRELIMINARY FIGURES FOR 2006 Geneva, Switzerland | English German French | |
| 28/02/2007 | MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A. Geneva, Switzerland | English | |
| 30/01/2007 | MERCK SERONO LAUNCHES EASYPOD®, FIRST ELECTRONIC GROWTH HORMONE INJECTION DEVICE
Geneva, Switzerland | English German French | |
| 24/01/2007 | MERCK SERONO HAS INITIATED THE ONWARD STUDY TO EVALUATE ORAL CLADRIBINE AS ADD-ON TREATMENT FOR MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 16/01/2007 | MERCK SERONO COMPLETES PATIENT ENROLLMENT IN CLARITY PHASE III PIVOTAL CLINICAL TRIAL OF ORAL CLADRIBINE Geneva, Switzerland | English German French | |
| 16/01/2007 | MERCK SERONO ANNOUNCES POSITIVE RESULTS FROM PHASE III DIET STUDY OF PHENOPTIN FOR PHENYLKETONURIA Geneva, Switzerland | English German French | |
| 09/01/2007 | MERCK KGAA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES
Darmstadt, Germany | English | |
| 08/01/2007 | MERCK SERONO IS LAUNCHED Geneva, Switzerland | English German French | |
| 05/01/2007 | MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A. Geneva, Switzerland | English |
| 2006 | |||
| 20/12/2006 | ZYMOGENETICS AND SERONO BEGIN PHASE 2 CLINICAL TRIAL WITH ATACICEPT IN RHEUMATOID ARTHRITIS
Geneva, Switzerland | English German French | |
| 18/12/2006 | MERCK KGAA: EUROPEAN ANTITRUST AUTHORITIES CLEAR ACQUISITION OF SERONO
Geneva, Switzerland | English | |
| 12/12/2006 | SERONO ANNOUNCES INITIATION OF THE REFLEX TRIAL TO EVALUATE NEW FORMULATION OF REBIF® IN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland | English German French | |
| 13/11/2006 | ZYMOGENETICS AND SERONO REPORT DETAILED POSITIVE RESULTS FROM ATACICEPT PHASE 1B CLINICAL TRIAL IN PATIENTS WITH LUPUS
Seattle, USA and Geneva, Switzerland | English German French | |
| 31/10/2006 | 24-WEEK CLEAR STUDY RESULTS CONFIRM SUSTAINED EFFICACY AND SAFETY OF RAPTIVA® IN MODERATE-TO-SEVERE PSORIASIS PATIENTS WITH CO-MORBIDITIES Geneva, Switzerland | English German French | |
| 19/10/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 19/10/2006 | SERONO DELIVERS STRONG ADJUSTED* NET INCOME OF $183.5M IN THIRD QUARTER 2006
Geneva, Switzerland | English German French | |
| 16/10/2006 | SERONO AND NEWRON ANNOUNCE GLOBAL DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR SAFINAMIDE Geneva, Switzerland and Milan, Italy | English German French | |
| 02/10/2006 | FINAL DATA FROM TWO PHASE II TRIALS INDICATE ACTIVITY OF ADECATUMUMAB (MT201) IN BREAST AND PROSTATE CANCER
Carlsbad, CA and Geneva, Switzerland | English German French | |
| 28/09/2006 | ONE-YEAR DATA FROM PHASE III TRIAL SHOW THAT NEW FORMULATION OF REBIF® OFFERS SUBSTANTIAL IMPROVEMENT IN TOLERABILITY AND IMMUNOGENICITY PROFILES
Madrid, Spain | English French | |
| 25/09/2006 | PUBLICATION OF INTERESTS (Art. 21 LBVM [SWISS STOCK MARKET LAW])
Geneva, Switzerland | English German French | |
| 21/09/2006 | SERONO'S ORAL CLADRIBINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS AWARDED FAST TRACK STATUS BY FDA Geneva, Switzerland | English German French | |
| 21/09/2006 | MERCK KGAA TO ACQUIRE SERONO Geneva, Switzerland | English | |
| 18/09/2006 | SERONO AND SYNTONIX TO PURSUE THE DEVELOPMENT OF A LONG-ACTING, INHALEABLE FSH THERAPY TO TREAT INFERTILITY
Geneva, Switzerland and Waltham, Mass | English German French | |
| 12/09/2006 | BIOMARIN AND SERONO ANNOUNCE DATA ON PHENOPTIN IN PKU TO BE PRESENTED AT THE 56TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HUMAN GENETIC Novato, California and Geneva, Switzerland | English | |
| 26/07/2006 | SERONO DELIVERS SECOND QUARTER EPS OF $12.92, UP 25.2% ON ADJUSTED BASIS
Geneva, Switzerland | English German French | |
| 26/07/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 24/07/2006 | SERONO INITIATES FIRST LARGE SCALE EUROPEAN PHARMACO-EPIDEMIOLOGICAL STUDY IN PSORIASIS TO FURTHER DOCUMENT THE DEMONSTRATED LONG-TERM SAFETY PROFILE OF RAPTIVA® Geneva, Switzerland | English German French | |
| 10/07/2006 | EUROPEAN COMMISSION APPROVES REVISION OF THERAPEUTIC INDICATION FOR REBIF®
Geneva, Switzerland | English German French | |
| 26/06/2006 | ZYMOGENETICS AND SERONO PRESENT POSITIVE RESULTS OF TACI-IG PHASE 1B TRIAL IN RHEUMATOID ARTHRITIS AT EULAR MEETING Seattle, USA and Geneva, Switzerland | English German French | |
| 22/06/2006 | COMPELLING EVIDENCE OF RAPTIVA® 12-WEEK CLEAR TRIAL DATA IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS PUBLISHED IN BRITISH JOURNAL OF DERMATOLOGY
Geneva, Switzerland | English German French | |
| 09/05/2006 | SERONO ANNOUNCES NEW APPOINTMENTS TO ITS EXECUTIVE MANAGEMENT BOARD Geneva, Switzerland | English German French | |
| 25/04/2006 | SERONO SHAREHOLDERS APPROVE RESOLUTIONS AT ANNUAL GENERAL MEETING Geneva, Switzerland | English German French | |
| 20/04/2006 | SERONO DELIVERS STRONG FIRST QUARTER 2006 WITH REVENUE GROWTH OF 16.4% IN LOCAL CURRENCIES Geneva, Switzerland | English German French | |
| 20/04/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 10/04/2006 | SERONO ANNOUNCES TERMINATION OF DISCUSSIONS CONCERNING A SALE OF THE COMPANY
Geneva, Switzerland | English German French | |
| 04/04/2006 | SERONO SUBMITS NEW FORMULATION OF REBIF® FOR APPROVAL IN THE UNITED STATES AND IN EUROPE
Geneva, Switzerland and Rockland, MA | ||
| 31/03/2006 | SERONO’S BOARD OF DIRECTORS TO PROPOSE AN INCREASE IN AUTHORIZED SHARE CAPITAL TO THE FORTHCOMING ANNUAL SHAREHOLDERS’ MEETING TO PROVIDE THE COMPANY WITH FINANCING CAPACITY Geneva, Switzerland | English German French | |
| 15/03/2006 | BIOMARIN AND SERONO ANNOUNCE POSITIVE RESULTS FROM PHASE 3 CLINICAL STUDY OF PHENOPTIN FOR PKU
Novato, CA and Geneva, Switzerland | English German French | |
| 06/02/2006 | SERONO'S 2005 ADJUSTED* EPS INCREASED BY 34.6% Geneva, Switzerland | English German French | |
06/02/2006 | FINANCIAL TABLES Geneva, Switzerland | English | |
| 24/01/2006 | SERONO’S GONAL-F® APPROVED IN JAPAN FOR THE TREATMENT OF MALE HYPOGONADOTROPIC HYPOGONADISM Geneva, Switzerland | English German French | |
| 09/01/2006 | SERONO COMPLETES SECOND PHASE III TRIAL OF ITS PROPRIETARY Geneva, Switzerland and Rockland, MA | English German French |
